HOME >> MEDICINE >> NEWS
MacroChem completes patient enrollment for Phase II trial of EcoNail for treatment of onychomycosis

Wellesley Hills, MA, April 11 -- MacroChem Corporation (OTCBB: MACM.OB) announced the completion of patient enrollment in a 40 patient U.S. multi-center open label Phase II efficacy study of EcoNail, a topical antifungal lacquer for the treatment of onychomycosis (nail fungus). EcoNail is the company's patented lacquer which contains the antifungal econazole and MacroChem's enhancer SEPA.

Patients participating in the study, which is being conducted under MacroChem's U.S. Investigational New Drug application filed with the FDA, will receive 48 weeks of treatment and will undergo efficacy assessments using standard criteria of nail appearance and mycology. However, the Company will collect and evaluate 24-week interim data later this year. This trial was specifically designed, with the assistance of well-known onychomycosis experts, to address three important objectives: to assess early signs of efficacy, to maintain robust clinical endpoints in the full study, and, if successful, to facilitate advancement to Phase III as soon as possible.

"Full enrollment in this Phase II study is an important milestone in advance of our planned interim assessment later this year. An earlier than originally intended evaluation of clinical data from a subset of patients treated for 24 weeks may be conducted to facilitate planning for potential future clinical development", stated Robert DeLuccia, President and CEO of MacroChem. He continued, "I believe that the recent precedent-setting deal activity for topical nail fungus products in clinical development by two major international pharmaceutical companies reflects the high level of interest in the marketplace for new treatments for onychomycosis."

DeLuccia further noted: "If we can develop a topical therapy without the treatment-limiting side effects experienced with the current market-leading oral products and with better efficacy than the only currently available topical product, we believe this c
'"/>

Contact: Rachel Anscher
ranscher@investorrelationsgroup.com
212-825-3210
MacroChem
11-Apr-2007


Page: 1 2

Related medicine news :

1. Asthmatx completes enrollment in pivotal study of bronchial thermoplasty
2. Acrux completes enrollment in key phase 2 trial
3. GroPep completes final milestone of the path malaria vaccine initiative
4. Im a Kid Too project completes first phase
5. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
6. Comparison of obstetric outcomes between on-call and patients own obstetricians
7. Test project of patient-centered medical home model endorsed by American College of Physicians
8. Researchers find vitamin B1 deficiency key to vascular problems for diabetic patients
9. Stem cell transplantation procedure results in long-term survival for amyloidosis patients
10. Happier hospitals means healthier patients
11. Many heart attack patients still not getting emergency clot-busting treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... TAMPA, Fla. (PRWEB) , ... August 05, 2020 , ... ... safety strategy for safely reopening for class on Monday, August 12, 2020. AdventHealth provided ... limiting the spread of COVID-19 in the classroom setting. , “We are taking ...
(Date:8/5/2020)... ... , ... Hypoglycemia (low blood glucose levels) in hospitalized patients ... even death. A researcher at the VA Maryland Health Care System, conducted the ... the use of continuous glucose monitoring devices can prevent hypoglycemia in inpatients on ...
(Date:8/5/2020)... ... August 05, 2020 , ... ... industry, as president of the largest veterinarian-owned purchasing Cooperative in the United States. ... various roles where she gained extensive knowledge and experience in the animal health ...
(Date:8/5/2020)... ... 2020 , ... Today, YPO Africa , a global leadership community of ... Africa, announced that they have entered into a unique bilateral alliance. The key aim ... other in their African impact efforts, with an initial focus on YPO’s Lead ...
(Date:8/5/2020)... Texas (PRWEB) , ... August 04, 2020 , ... ... older adults living with memory impairment, has announced the Best Memory Care Facilities ... access to experts, facility features and amenities. , According to the ...
Breaking Medicine News(10 mins):
(Date:8/3/2020)... ... August 03, 2020 , ... LaVoieHealthScience (LHS), ... innovations, today announced that Donna L. LaVoie, President, CEO and Founder of LHS, has ... industry. , Since 2005, the PharmaVOICE 100 has honored more than 1,500 industry ...
(Date:7/31/2020)... CITY, Texas (PRWEB) , ... July 31, 2020 , ... ... Design Studios has been providing residents of Missouri City, TX, with a wide ... Highway 6, Suite 300, is a state-of-the-art dental facility that is not far from ...
(Date:7/31/2020)... ... ... A June 29 article on Healthline reports on the belief of ... that inhabited the mouths of those afflicted. The article goes into various causes that ... found in water supplies. Marina Del Rey-based dental center Elegant Dentistry in Los Angeles ...
Breaking Medicine Technology:
Cached News: